Table 1

Baseline clinical and laboratory characteristics of 312 patients with Child A cirrhosis in the different aetiological subgroups

HCV+/HBsAg− (n = 254)HCV−/HBsAg+ (n = 43)HCV+/HBsAg+ (n = 15)p Value
*Values are median (range).
HBV, hepatitis B virus; HCV, hepatitis C virus; HBsAg, hepatitis B surface antigen; ALT, alanine aminotransferase.
†Kruskal-Wallis test; ‡χ2 test.
Age (y)*61 (36–78)52 (30–74)60 (43–68)<0.0001†
Sex
    Males142 (55.9%)38 (88.4%)12 (80.0%)<0.0001‡
    Females112 (44.1%)5 (11.6%)3 (20.0%)
Duration of cirrhosis (y)*0 (0–6)0 (0–5)0 (0–6)0.92†
Alcohol abuse34 (13.4%)8 (18.6%)4 (26.7%)0.25‡
Albumin (g/l)*42 (32–53)42 (30–54)40 (35–47)0.49†
Prothrombin time (%)*85 (50–100)76 (55–100)70 (63–92)<0.0001†
Total bilirubin (μmol/l)*14 (3–44)15 (3–39)17 (4–34)0.53†
Platelets count (×109/l)*131 (31–294)140 (61–239)122 (89–257)0.80†
Leucocytes count (×109/l)*5.0 (2.0–9.8)5.4 (2.7–8.3)6.0 (3.8–9.2)0.22†
ALT (U/l)*130 (18–973)116 (14–750)127 (37–613)0.82†
Follow up (months)*91 (14–194)112 (39–175)82 (50–177)0.12†